An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR)

NCT00606541 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

55

Enrollment

OTHER

Sponsor class

Stopped The study was terminated by the sponsor due to budgetary issues

Conditions

Social Anxiety Disorder

Interventions

DRUG: Quetiapine XR
DRUG: Placebo

Sponsor

Duke University